Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable |
Is a |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL prefilled syringe |
Is a |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL cartridge |
Is a |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin aspart (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml inject |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart protamine |
Is a |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin aspart and insulin degludec (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart- and insulin degludec-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing insulin aspart in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart protamine |
Is modification of (attribute) |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only insulin aspart (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart and insulin degludec only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart and insulin degludec only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only insulin aspart in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart 100 unit/mL solution for injection |
Has basis of strength substance (attribute) |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin aspart 100 unit/mL solution for injection |
Has precise active ingredient |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
insulina aspartat |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |